R-01301021 Executive Epidemiology Researcher - Safety Outcomes, Evider…
Thermo Fisher ScientificSalary not specified
- Full Time
- Senior (5 to 8 years)
Not SpecifiedCompensation
InternshipExperience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries
Requirements
Candidates must hold a doctoral degree in an appropriate discipline such as economics, epidemiology, health services, pharmacoeconomics, psychology, statistics, or another relevant science. Experience in health economic and outcomes research (HEOR), health services research (HSR), or real-world evidence (RWE) is preferred. Strong analytical skills, including expertise in statistical analysis, economic modeling, clinical trials, observational/epidemiologic research, and health technology assessment, are required. Familiarity with common statistical software and an understanding of clinical, economic, and patient-reported outcomes methodologies are also necessary.
Responsibilities
The Postdoctoral Research Scientist will develop health outcomes research for patients, population-based decision-makers, and providers, focusing on disease states and health services of interest to Lilly. They will execute health outcomes studies, conduct analytics, and utilize analytical tools. The role involves communicating study findings to internal audiences and disseminating them to the scientific community, collaborating with medical affairs and commercial teams, and supporting the Lilly portfolio of medications by increasing or developing knowledge and use of real-world evidence, patient-focused outcomes, economic modeling, and health technology assessment submissions. The candidate will also contribute to the development of various types of research studies for publication and increase understanding of healthcare systems in the US and clinical trial research.
Skills
Health Economics
Outcomes Research
Health Services Research
Real-World Evidence
Statistical Analysis
Economic Modeling
Clinical Trials
Epidemiologic Research
Health Technology Assessment
Eli Lilly and Company
Develops and delivers prescription medicines globally
About Eli Lilly and Company
Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.
Key Metrics
Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees